ATE323497T1 - Idraparinux (sanorg 34006) zur behandlung und sekundärprophylaxe von thromboembolien bei patienten mit tiefer venenthrombose - Google Patents
Idraparinux (sanorg 34006) zur behandlung und sekundärprophylaxe von thromboembolien bei patienten mit tiefer venenthromboseInfo
- Publication number
- ATE323497T1 ATE323497T1 AT03702514T AT03702514T ATE323497T1 AT E323497 T1 ATE323497 T1 AT E323497T1 AT 03702514 T AT03702514 T AT 03702514T AT 03702514 T AT03702514 T AT 03702514T AT E323497 T1 ATE323497 T1 AT E323497T1
- Authority
- AT
- Austria
- Prior art keywords
- sanorg
- idraparinux
- thromboembolism
- patients
- treatment
- Prior art date
Links
- AJBMORBNKXNZSF-COSHMZDQSA-N (2s,3s,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3s,4s,5r,6r)-2-carboxy-4,5-dimethoxy-6-[(2r,3r,4s,5r,6s)-6-methoxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-4,5-dimethoxy-3-[(2r,3r,4s,5r,6r)-3,4 Chemical compound OS(=O)(=O)O[C@@H]1[C@@H](OS(O)(=O)=O)[C@@H](OC)O[C@H](COS(O)(=O)=O)[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@H](O[C@H]3[C@@H]([C@@H](OC)[C@H](O[C@@H]4[C@@H]([C@@H](OC)[C@H](OC)[C@@H](COS(O)(=O)=O)O4)OC)[C@H](O3)C(O)=O)OC)[C@@H](COS(O)(=O)=O)O2)OS(O)(=O)=O)[C@H](C(O)=O)O1 AJBMORBNKXNZSF-COSHMZDQSA-N 0.000 title 1
- 206010051055 Deep vein thrombosis Diseases 0.000 title 1
- 208000005189 Embolism Diseases 0.000 title 1
- 208000001435 Thromboembolism Diseases 0.000 title 1
- 206010047249 Venous thrombosis Diseases 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02075374 | 2002-01-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE323497T1 true ATE323497T1 (de) | 2006-05-15 |
Family
ID=27635850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03702514T ATE323497T1 (de) | 2002-01-29 | 2003-01-23 | Idraparinux (sanorg 34006) zur behandlung und sekundärprophylaxe von thromboembolien bei patienten mit tiefer venenthrombose |
Country Status (23)
Country | Link |
---|---|
US (1) | US7709463B2 (de) |
EP (1) | EP1471924B1 (de) |
JP (1) | JP4870907B2 (de) |
CN (1) | CN1622813A (de) |
AR (1) | AR038320A1 (de) |
AT (1) | ATE323497T1 (de) |
AU (1) | AU2003205664B2 (de) |
BR (1) | BR0307196A (de) |
CA (1) | CA2472957C (de) |
CY (1) | CY1107661T1 (de) |
DE (1) | DE60304678T2 (de) |
DK (1) | DK1471924T3 (de) |
EA (1) | EA007204B1 (de) |
ES (1) | ES2262971T3 (de) |
HK (1) | HK1072361A1 (de) |
MX (1) | MXPA04007310A (de) |
NO (1) | NO332699B1 (de) |
PE (1) | PE20030855A1 (de) |
PL (1) | PL207144B1 (de) |
PT (1) | PT1471924E (de) |
SI (1) | SI1471924T1 (de) |
TW (1) | TWI281861B (de) |
WO (1) | WO2003063881A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR052419A1 (es) * | 2004-12-01 | 2007-03-21 | Osi Pharm Inc | Derivados de bencimidazolil n-sustituidos,inhibidores del protooncogen c-kit |
WO2012166611A2 (en) | 2011-05-27 | 2012-12-06 | Immune Disease Institute, Inc. | Methods for treating and preventing neutrophil-derived net toxicity and thrombosis |
CN114616340A (zh) | 2019-07-09 | 2022-06-10 | 奥普蒂姆维亚有限公司 | 合成抗凝血多糖的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378829A (en) * | 1990-04-23 | 1995-01-03 | Akzo N.V. | Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type |
-
2003
- 2003-01-14 TW TW092100703A patent/TWI281861B/zh not_active IP Right Cessation
- 2003-01-23 DK DK03702514T patent/DK1471924T3/da active
- 2003-01-23 MX MXPA04007310A patent/MXPA04007310A/es active IP Right Grant
- 2003-01-23 CN CNA038028123A patent/CN1622813A/zh active Pending
- 2003-01-23 ES ES03702514T patent/ES2262971T3/es not_active Expired - Lifetime
- 2003-01-23 SI SI200330334T patent/SI1471924T1/sl unknown
- 2003-01-23 EA EA200400817A patent/EA007204B1/ru not_active IP Right Cessation
- 2003-01-23 PL PL370557A patent/PL207144B1/pl unknown
- 2003-01-23 CA CA2472957A patent/CA2472957C/en not_active Expired - Fee Related
- 2003-01-23 PE PE2003000071A patent/PE20030855A1/es not_active Application Discontinuation
- 2003-01-23 AT AT03702514T patent/ATE323497T1/de active
- 2003-01-23 DE DE60304678T patent/DE60304678T2/de not_active Expired - Lifetime
- 2003-01-23 US US10/502,706 patent/US7709463B2/en not_active Expired - Fee Related
- 2003-01-23 PT PT03702514T patent/PT1471924E/pt unknown
- 2003-01-23 BR BR0307196-0A patent/BR0307196A/pt not_active Application Discontinuation
- 2003-01-23 EP EP03702514A patent/EP1471924B1/de not_active Expired - Lifetime
- 2003-01-23 AU AU2003205664A patent/AU2003205664B2/en not_active Ceased
- 2003-01-23 WO PCT/EP2003/000696 patent/WO2003063881A1/en active IP Right Grant
- 2003-01-23 JP JP2003563570A patent/JP4870907B2/ja not_active Expired - Fee Related
- 2003-01-28 AR ARP030100237A patent/AR038320A1/es not_active Application Discontinuation
-
2004
- 2004-07-27 NO NO20043195A patent/NO332699B1/no not_active IP Right Cessation
-
2005
- 2005-05-03 HK HK05103708A patent/HK1072361A1/xx not_active IP Right Cessation
-
2006
- 2006-07-19 CY CY20061101002T patent/CY1107661T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2003205664B2 (en) | 2008-06-05 |
HK1072361A1 (en) | 2005-08-26 |
CY1107661T1 (el) | 2013-04-18 |
ES2262971T3 (es) | 2006-12-01 |
NO20043195L (no) | 2004-10-29 |
CA2472957C (en) | 2011-09-13 |
NO332699B1 (no) | 2012-12-10 |
US20050209175A1 (en) | 2005-09-22 |
PE20030855A1 (es) | 2003-10-11 |
US7709463B2 (en) | 2010-05-04 |
DE60304678T2 (de) | 2007-04-05 |
CA2472957A1 (en) | 2003-08-07 |
TW200302104A (en) | 2003-08-01 |
JP2005519919A (ja) | 2005-07-07 |
SI1471924T1 (sl) | 2006-10-31 |
EA200400817A1 (ru) | 2005-02-24 |
PT1471924E (pt) | 2006-09-29 |
JP4870907B2 (ja) | 2012-02-08 |
BR0307196A (pt) | 2004-11-03 |
PL207144B1 (pl) | 2010-11-30 |
CN1622813A (zh) | 2005-06-01 |
WO2003063881A1 (en) | 2003-08-07 |
PL370557A1 (en) | 2005-05-30 |
EP1471924B1 (de) | 2006-04-19 |
TWI281861B (en) | 2007-06-01 |
AR038320A1 (es) | 2005-01-12 |
DK1471924T3 (da) | 2006-08-21 |
EA007204B1 (ru) | 2006-08-25 |
MXPA04007310A (es) | 2004-10-29 |
EP1471924A1 (de) | 2004-11-03 |
DE60304678D1 (de) | 2006-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60222671D1 (de) | Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen | |
DE60023128D1 (de) | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen | |
DE60108080D1 (de) | Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen | |
DE60114808D1 (de) | Oberflächenbehandlung von medizinischer vorrichtung | |
DE60327622D1 (de) | Kombinierte antitachykardie - schrittmacher und hochspannungstherapie zur behandlung von ventrikulären arrhythmien | |
DE60223715D1 (de) | Glyt1 transporter inhibitoren und deren anwendung in der behandlung von neurologischen und neuropsychiatischen krankheiten | |
ATE389649T1 (de) | Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen | |
ATE319453T1 (de) | Reboxetin zur behandlung von fibromyalgie und anderen somatoformen störungen | |
DE60322582D1 (de) | Oberflächenbehandlung von medizinischem gerät | |
DE60310136D1 (de) | Wasserabweisende oberflächenbehandlung und behandelte artikel | |
ATE542801T1 (de) | Zur behandlung von neoplastischen krankheiten, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4-pyrimidindiamine | |
ZA200500719B (en) | The use of the combination of ciclesonide and antihitamines for the treatment of allergic rhinitis. | |
DE602004010708D1 (de) | Imidazopyridinsubstituierte tropanderivate mit ccr5-rezeptorantagonistischer wirkung zur behandlung von hiv und entzündungen | |
DE50212701D1 (de) | Bestrahlungsanordnung zur behandlung von akne und aknenarben | |
DE60216275D1 (de) | Verwendung von mit azetidinon substituierten derivaten bei der behandlung der alzheimer-krankheit | |
DE60233265D1 (de) | 5-sulfanyl-4h-1,2,4-triazolderivate und deren verwendung zur behandlung von somatostatine vermittelten krankheiten | |
ATE381347T1 (de) | Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen | |
DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
IS6966A (is) | Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma | |
ATE398445T1 (de) | Co-perlchen von dha und rosmarin und verwendungsverfahren | |
IS6967A (is) | Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma | |
DE60206289D1 (de) | Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne | |
DE60027429D1 (de) | Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien | |
EP1441761A4 (de) | Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren | |
ATE347888T1 (de) | Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1471924 Country of ref document: EP |